KEGG   DRUG: Moroctocog alfa
Entry
D08232                      Drug                                   
Name
Moroctocog alfa (INN);
ReFacto (TN)
Formula
C3953H6020N1040O1158S29. C3553H5412N956O1028S33
Exact mass
166490.7433
Mol weight
166595.29
Class
Blood modifier agent
 DG02016  Hemostatics
  DG02014  Blood coagulation accelerant
   DG02013  Blood coagulation factor
Remark
ATC code: B02BD02
Chemical structure group: DG00170
Product (DG00170): D08798<JP> D05409<JP> D10227<JP> D10539<JP> D10758<JP> D10759<JP> D10760<JP> D10771<JP> D10818<JP> D10831<JP> D10842<JP> D12441<JP>
Efficacy
Bleeding suppressant, Replenisher (coagulation factor)
Comment
recombinant Factor VIII (BDDrFVIII) [HSA:2157] [KO:K03899]
Blood-coagulation factor
Target
F8* [HSA_VAR:2157v1] [HSA:2157] [KO:K03899]
  Pathway
hsa04610  Complement and coagulation cascades
  Network
nt06514  Coagulation cascade
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B02 ANTIHEMORRHAGICS
   B02B VITAMIN K AND OTHER HEMOSTATICS
    B02BD Blood coagulation factors
     B02BD02 Coagulation factor VIII
      D08232  Moroctocog alfa (INN)
Drug groups [BR:br08330]
 Blood modifier agent
  DG02016  Hemostatics
   DG02014  Blood coagulation accelerant
    DG02013  Blood coagulation factor
     DG00170  Blood coagulation factor VIII
      D08232  Moroctocog alfa
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    F8* [HSA_VAR:2157v1]
     D08232  Moroctocog alfa (INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D08232
Drug groups [BR:br08330]
 Blood modifier agent
  DG02016  Hemostatics
   DG02014  Blood coagulation accelerant
    DG02013  Blood coagulation factor
     DG00170  Blood coagulation factor VIII
Other DBs
CAS: 284036-24-4
PubChem: 96024920
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system